A detailed history of Bridge Creek Capital Management LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Bridge Creek Capital Management LLC holds 3,065 shares of ABT stock, worth $353,302. This represents 0.11% of its overall portfolio holdings.

Number of Shares
3,065
Previous 3,080 0.49%
Holding current value
$353,302
Previous $320,000 9.06%
% of portfolio
0.11%
Previous 0.1%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$100.07 - $118.13 $1,501 - $1,771
-15 Reduced 0.49%
3,065 $349,000
Q2 2024

Jul 15, 2024

SELL
$100.73 - $112.44 $103,751 - $115,813
-1,030 Reduced 25.06%
3,080 $320,000
Q1 2024

Apr 11, 2024

SELL
$109.52 - $120.96 $2,738 - $3,024
-25 Reduced 0.6%
4,110 $467,000
Q4 2022

Jan 24, 2023

BUY
$95.06 - $111.52 $2,376 - $2,788
25 Added 0.61%
4,135 $0
Q3 2022

Oct 13, 2022

BUY
$96.76 - $112.03 $677 - $784
7 Added 0.17%
4,110 $398,000
Q1 2022

May 12, 2022

BUY
$114.02 - $139.04 $2,052 - $2,502
18 Added 0.44%
4,103 $486,000
Q1 2021

Apr 09, 2021

SELL
$108.84 - $128.23 $7,074 - $8,334
-65 Reduced 1.57%
4,085 $490,000
Q3 2020

Oct 16, 2020

SELL
$91.64 - $111.29 $4,582 - $5,564
-50 Reduced 1.19%
4,150 $452,000
Q1 2020

Apr 14, 2020

SELL
$62.82 - $91.86 $3,957 - $5,787
-63 Reduced 1.48%
4,200 $331,000
Q2 2019

Jul 12, 2019

SELL
$72.88 - $85.0 $1,822 - $2,125
-25 Reduced 0.58%
4,263 $359,000
Q1 2019

Apr 05, 2019

BUY
$66.22 - $80.06 $20,726 - $25,058
313 Added 7.87%
4,288 $343,000
Q4 2018

Jan 18, 2019

SELL
$65.56 - $74.27 $3,278 - $3,713
-50 Reduced 1.24%
3,975 $288,000
Q3 2017

Oct 12, 2017

BUY
$48.06 - $53.64 $193,441 - $215,901
4,025
4,025 $215,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $202B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Bridge Creek Capital Management LLC Portfolio

Follow Bridge Creek Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridge Creek Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridge Creek Capital Management LLC with notifications on news.